Company Website

Contact Information:

Janet Huss
jhuss@epizyme.com
763-639-0742

Virtual Exhibit Hall Home

Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.

Join us for a virtual meeting room for August 20 and August 21

August 20: https://epizyme.webex.com/epizyme/j.php?MTID=mac0b5cb90cee076068be67f2f35727ea
August 21: https://epizyme.webex.com/epizyme/j.php?MTID=m178ffd784ab71bb1eb108cfde9baa9f4

Additional Information
Tazverik in Follicular Lymphoma
Package Insert
Epizyme Now Patient Support Program